877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Phenethylamines, Norepinephrine-dopamine reuptake inhibitors

Categories

Drugs acting on the nervous system (8)
Monoamine reuptake inhibitors (8)
Psychoactive drugs (8)
Psychoanaleptics (7)
Stimulants (7)
Cyclic compounds (5)
Euphoriants (4)
Cathinones (3)
Drugs acting on the gastrointestinal system and metabolism (3)
Substituted amphetamines (3)
5-HT3 antagonists (2)
Analgesics (2)
Androgens and anabolic steroids (2)
Anorectics (2)
Antidepressants (2)
Antiemetics (2)
Antiobesity drugs (2)
Aphrodisiacs (2)
Aromatic compounds (2)
Chloroarenes (2)
Drugs acting on the cardiovascular system (2)
Drugs acting on the genito-urinary system (2)
Estrogens (2)
Female sexual dysfunction drugs (2)
Libido (2)
Methylphenidate (2)
Mu-opioid agonists (2)
Nootropics (2)
Opioid receptor ligands (2)
Opioids (2)
Pharmaceuticals (2)
Piperidines (2)
Psychopharmacology (2)
Sex hormones (2)
Sexual dysfunction drugs (2)
Six-membered rings (2)
Testosterone (2)
Vasoconstrictors (2)
Five-membered rings (1)
Gastrointestinal system drug (1)
Pyrrolidines (1)

bupropion (34841-39-9, 34911-55-2)  
Wellbutrin  ·  Bupropion Hydrochloride  ·  Quomen
Bupropion is a medication primarily used as an antidepressant and smoking cessation aid. It is marketed as Wellbutrin and Zyban among other trade names. It is one of the most frequently prescribed antidepressants in the United States and Canada, although in many countries this is an off-label use.
methylphenidate (113-45-1)  
Ritalin  ·  Concerta  ·  Methylphenidate Hydrochloride
Methylphenidate, sold under various trade names, Ritalin being one of the most commonly known, is a central nervous system (CNS) stimulant of the phenethylamine and piperidine classes that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. The original patent was owned by CIBA, now Novartis Corporation. It was first licensed by the US Food and Drug Administration (FDA) in 1955 for treating what was then known as hyperactivity.
Dexmethylphenidate (40431-64-9)  
Dexmethylphenidate, sold under the trade names Focalin among others, is a central nervous system (CNS) stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is in the phenethylamine and piperidine classes of medications. It is the active dextrorotatory enantiomer of methylphenidate.
PYROVALERONE (3563-49-3)  
Pyrovalerone (Centroton, 4-Methyl-β-keto-prolintane, Thymergix, O-2371) is a psychoactive drug with stimulant effects via acting as a norepinephrine-dopamine reuptake inhibitor (NDRI), and is used for the clinical treatment of chronic fatigue or lethargy and as an anorectic or appetite suppressant for weight loss purposes. It was developed in the late 1960s and has since been used in France and several other European countries, and although pyrovalerone is still occasionally prescribed, it is used infrequently due to problems with abuse and dependence. It is closely related on a structural level to a number of other stimulants, such as MDPV and prolintane (Promotil, Katovit).
Prolintane (493-92-5)  
1-(alpha-propylphenethyl)pyrrolidine  ·  Promotil  ·  phenylpyrrolidinylpentan
Prolintane (Catovit, Katovit, Promotil, Villescon) is a stimulant and norepinephrine-dopamine reuptake inhibitor developed in the 1950s. It is closely related in chemical structure to other drugs such as pyrovalerone, MDPV, and propylhexedrine and it has a similar mechanism of action. Many cases of prolintane abuse have been reported.
Lefetamine (6319-84-2, 7262-75-1)  
Lefetamine (Santenol) is a drug which is a stimulant and also an analgesic with effects comparable to codeine. Lefetamine-related 1,2-diphenylethylamines were invented in the 1940s and showed weak analgesic activity. It was investigated in Japan in 1950s.
NSC 31924 (6319-84-2)  
Lefetamine (Santenol) is a drug which is a stimulant and also an analgesic with effects comparable to codeine. Lefetamine-related 1,2-diphenylethylamines were invented in the 1940s and showed weak analgesic activity. It was investigated in Japan in 1950s.
Related searches
Phenethylamines
Norepinephrine-dopamine reuptake inhibitors